TITLE

Selection of Patients for Clinical Trials

AUTHOR(S)
Tyrer, Peter
PUB. DATE
November 1973
SOURCE
British Medical Journal;11/10/1973, Vol. 4 Issue 5888, p358
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
No abstract available.
ACCESSION #
64108789

 

Related Articles

  • SLT an Effective Initial Therapy For OAG or Ocular Hypertension.  // Review of Ophthalmology;Oct2012, Vol. 19 Issue 10, p83 

    The article offers information on clinical trials which reports that the selective laser trabeculoplasty is a safe therapy for treating patients with glaucoma.

  • Regular Review: Clinical experimentation in obstetrics. Lilford, R.J. // British Medical Journal (Clinical Research Edition);11/21/1987, Vol. 295 Issue 6609, p1298 

    Describes clinical experimentation in obstetrics. Selection of control patients; Problems of obstetrician-scientists; Acceptance of randomized trials.

  • Bacterial Superantigens. Kuznar, Wayne // Dermatology Times;Oct2003, Vol. 24 Issue 10, p36 

    Reports on the antibiotics that reduce the inflammation in selected psoriatic and atopic patients in the U.S. Role of superantigen; Clinical trials on the efficacy of antibiotics; Clinical course of the disease.

  • Selective reporting of positive results from drug clinical trials is a well-documented problem, but a new study finds that trials of surgical treatments have an even worse track record.  // MondayMorning;3/18/2013, Vol. 21 Issue 10, p1 

    The article presents information on a study related to selective reporting of trials of surgical treatments and other clinical trials. It informs that selective reporting of positive results from drug clinical trials is a well documented problem, but the trials of surgical treatments have an...

  • Interpreting Treatment Differences When Patients Drop Out of a Clinical Trial. Lindsey, Jane C.; McGrath, Nuala M. // AIDS Patient Care & STDs;Apr98, Vol. 12 Issue 4, p275 

    Presents information on how drugs are selected for the treatment of the human immunodeficiency virus (HIV) disease in patients using a clinical trial. How the drugs are judged; Identification of the Pediatric Aids Clinical Trials Group (PACTG) Protocol 051; What happens when a patient drop out...

  • IMPROVING THE UTILITY OF ACR CRITERIA FOR CLINICAL TRIALS.  // Lupus;Jan2001 Supplement 1, Vol. 10, pS117 

    An abstract of the article "Improving the Utility of ACR Criteria for Clinical Trials" is presented. The authors discuss the standards for the eligibility of clinical trials for patients with sytematic lupus erythematosus. Moreover, they conclude that inclusion of patients with milder disease...

  • Randomisation methods: concealment. Torgerson, David; Roberts, Chris // BMJ: British Medical Journal (International Edition);08/07/99, Vol. 319 Issue 7206, p375 

    Focuses on randomization methods for removing selection bias between two groups of patients in clinical trials. Importance of concealed randomization; Information on the sealed envelope system; Advantage of distance randomized clinical trials.

  • Joining clinical trials offers a chance to help profession. Singerman, Lawrence; Mittra, Robert A. // Ophthalmology Times;01/15/2000, Vol. 25 Issue 2, p12 

    Discusses the benefits of joining a clinical trial for ophthalmologists. Selection of investigators for the clinical trials; Importance of personnel in a successful clinical trial investigation; Best training for clinical trials.

  • Antidepressants and adverse effects in young patients: uncovering the evidence. Herxheimer, Andrew; Mintzes, Barbara // CMAJ: Canadian Medical Association Journal;2/17/2004, Vol. 170 Issue 4, p487 

    Addresses the need for premarket clinical trials of antidepressants in order to determine their efficiency and the harmful effects they may have on young patients. Warning against the use of selective serotonin reuptake inhibitors; Duration of most randomized trials of antidepressants; Value of...

  • Clinical profile and management of heart failure: rural community hospital vs. metropolitan heart center. Taubert, G.; Bergmeier, C.; Andresen, H.; Senges, J.; Potratz, J. // European Journal of Heart Failure;Oct2001, Vol. 3 Issue 5, p611 

    Background:: Knowledge on clinical characteristics and prognosis of patients with heart failure originates from studies of selected populations in clinical trials or from epidemiological observations. Reports on the large numbers of patients with heart failure treated in community hospitals are...

Share

Read the Article

Other Topics